BrainAurora joins Beijing Frontier BCI Institute to accelerate clinical translation of brain-computer interface technologies

BrainAurora Medical Technology Limited ( (HK:6681) ) just unveiled an announcement.

BrainAurora Medical Technology Limited has become a strategic partner of the newly established Beijing Frontier Brain-Computer Interface Institute, founded under the initiative of Xuanwu Hospital, Capital Medical University, to drive breakthroughs and clinical translation in brain-computer interface technologies. The partnership aligns BrainAurora’s cognitive impairment digital therapeutics expertise with Beijing’s push to build a leading, world-class BCI research and development hub.

Under a strategic cooperation agreement signed on March 27, 2026, BrainAurora and the Institute will jointly develop key initiatives such as a multimodal neurological disease database, a neuroelectrophysiological large-scale model, and closed-loop neuromodulation BCI products. The collaboration is expected to accelerate full-chain clinical translation of BCI technologies in China, address the needs of more than 100 million patients with neurological disorders, and strengthen an innovation ecosystem that tightly integrates engineering, medical sciences, and industry-academia cooperation.

The most recent analyst rating on (HK:6681) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on BrainAurora Medical Technology Limited stock, see the HK:6681 Stock Forecast page.

More about BrainAurora Medical Technology Limited

BrainAurora Medical Technology Limited is a China-focused medical technology company specializing in digital therapeutics for cognitive impairment, combining brain science with artificial intelligence. Through its subsidiaries, including Zhejiang BrainAurora Medical Technology Co., Ltd., the group targets the rapidly developing brain-computer interface sector and broader high-end medical equipment market, with an emphasis on clinical applications in medical rehabilitation.

Average Trading Volume: 25,740,614

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$5.61B

For detailed information about 6681 stock, go to TipRanks’ Stock Analysis page.